These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo ...

Aug 31, 2024 · 1. The supply constraints blocking Lilly's revenue growth are easing. It's well-known that sales of new weight-loss drugs are powering earnings growth and share-price …

CouponFollow Extension

19%
OFF

Better Buy: Eli Lilly Vs. Novo Nordisk. The Answer Is Becoming ...

4 weeks from now

6 days ago · Enter Eli Lilly (LLY-1.19%) and Novo Nordisk (NVO-1.88%), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, …

fool.com

77%
OFF

Better Buy: Novo Nordisk Vs. Eli Lilly | The Motley Fool

4 weeks from now

While Ozemipc is the brand name on everyone's lips when they talk about weight loss, it's only approved to control blood sugar and reduce the risk of heart attacks for patients with type 2 diabetes. Nevertheless, Ozempic sales soared 77% last year to $8.8 billion with help from off-labelweight-loss prescriptions as well as diabetes patients. Invest...

fool.com

$580
OFF

After Earnings, Is Eli Lilly Stock A Buy, A Sell, Or Fairly Valued?

4 weeks from now

Aug 15, 2024 · We increased our fair value estimate to $580 per share from $540 following better-than-expected second-quarter results, largely driven by Mounjaro and Zepbound. However, …

morningstar.com

11%
OFF

These 3 Factors Could Make Eli Lilly Stock A Better Buy Than Novo ...

4 weeks from now

Aug 31, 2024 · This competitive showdown just saw one of the players hit a couple of bumps. Eli Lilly (LLY 2.11%) and Novo Nordisk (NVO 1.19%) are big pharma peers. They're also each …

investorshealth.com

38%
OFF

1 Huge New Reason To Buy Eli Lilly Or Novo Nordisk Stock Right …

4 weeks from now

Oct 29, 2024 · As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (LLY-1.38%) and Novo Nordisk (NVO-0.32%), there's now one more big …

fool.com

17%
OFF

Dividends Done Right: 3 Stock Picks To Build Wealth The Smart Way

4 weeks from now

1 day ago · These zero-day-to-expiry options, or “0dte” trades, make up more than half of options activity tied to the S&P 500 index, up from 17% at the start of 2020, according to market …

seekingalpha.com

71%
OFF

Did Eli Lilly Just Say "Checkmate" To Novo Nordisk?

4 weeks from now

Dec 15, 2024 · Eli Lilly (LLY 3.71%) and Novo Nordisk ... Even if one performs better than another, there could be other factors across these different trials that affect the results. ...

fool.com

38%
OFF

2 Pharmaceutical Growth Stocks To Buy Now And Hold For Decades

4 weeks from now

4 days ago · Eli Lilly (LLY-1.38%) and Novo Nordisk (NVO-0.32%) have attracted a lot of attention over the past two years thanks to their advances in the weight loss therapy market. Both …

fool.com

35%
OFF

Is Now A Good Time To Buy The Dip In Eli Lilly Stock?

4 weeks from now

Dec 21, 2024 · Since pharmaceutical giant Eli Lilly (LLY 1.35%) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock …

fool.com

FAQs about These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo ... Coupon?

Is Eli Lilly better than Novo Nordisk?

Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. Both Lilly and Novo Nordisk are experiencing unprecedented growth thanks to their weight loss medications. However, Lilly also treats cancer, plaque psoriasis, Alzheimer's disease, eczema, and more. ...

Are Novo Nordisk and Eli Lilly the hottest pharmaceutical stocks?

Novo Nordisk ( NVO 2.34%) and Eli Lilly ( LLY 0.13%) are two of the hottest pharmaceutical stocks of the past three years. Both companies have marked returns far in excess of the market's, thanks to popular demand for their freshly launched medications that treat obesity as well as type 2 diabetes. ...

Should investors invest in Eli Lilly & Novo Nordisk?

That means investors will have plenty of catalysts to possibly power outsized returns if things go as planned with the Food and Drug Administration (FDA). Much like Novo Nordisk, Eli Lilly's pipeline is chock-full of near-term opportunities to launch winning therapies, and it has a few strong performers in hand as well. ...

Is Eli Lilly stock a buy?

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation. ...

Is Lilly a good investment over Novo Nordisk?

I see Lilly as the superior investment over Novo Nordisk -- and frankly, I don't think it's even close. While I see the recent declines in Novo stock as a prime example of overblown panic selling, Lilly's progress against Wegovy -- combined with its diverse and growing medical portfolio -- make the company hard to pass up. ...

Should you buy Eli Lilly?

They're also each other's biggest rivals, especially in the all-important market for weight-loss drugs, in which both are currently highly successful. Right now, there are a few reasons to believe that Eli Lilly has the upper hand in this competitive clash. Those reasons support buying its stock, assuming you don't want to invest in both companies. ...